Humanin for Cardiac Health
Research, mechanism, dosing, and effectiveness of Humanin for cardiac health.
Quick Answer
Humanin shows cardioprotective effects in research.
Evidence Level
Animal Studies
Typical Dose
Research-stage
Results Timeline
Cardiac benefits in research models
FDA Status
Research Only
How Humanin Works for Cardiac Health
Protects cardiac cells from stress-induced damage.
About Cardiac Health
Support for heart function and cardiovascular health.
Research Evidence
Research shows protection against amyloid-beta toxicity in Alzheimer's models. Studies demonstrate improved insulin sensitivity, reduced atherosclerosis in animal models, and potential anti-aging effects. Human studies are limited.
Dosing for Cardiac Health
Recommended Dose
Research-stage
Frequency
2-3x weekly (e.g., Monday, Wednesday, Friday)
Administration
Injection (route varies)
Duration
Variable
Note: Subcutaneous injection to abdomen or thigh. Cycle 2-4 weeks on, 2-4 weeks off. Often stacked with MOTS-c and NAD+ for mitochondrial support. Store lyophilized at 0-5°C; reconstituted solution stable 5 days at 4°C or freeze for longer storage.
What to Expect
Initial adjustment period. Some users may notice subtle changes.
Early benefits often become noticeable. Continue consistent use.
Most users report meaningful improvements by this point.
Full effects typically realized. Reassess and adjust as needed.
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Generally well-tolerated (preclinical)
- •Mild injection site reactions
- •Potential pro-tumoral effects
- •May affect glucose metabolism
- •No human clinical trial data
Frequently Asked Questions
Does Humanin help with cardiac health?
Humanin shows cardioprotective effects in research.
How does Humanin work for cardiac health?
Protects cardiac cells from stress-induced damage....
What dose of Humanin should I use for cardiac health?
Research-stage
How long until I see results?
Cardiac benefits in research models
Other Peptides for Cardiac Health
These peptides are also researched for cardiac health.
FOXO4-DRI
PreclinicalA senolytic peptide designed to selectively eliminate senescent 'zombie' cells by disrupting the FOXO4-p53 interaction. Shows promise for restoring tissue function in aging, including kidney health restoration.
Vesilute
PreclinicalA synthetic dipeptide (Glu-Asp) bioregulator from the Khavinson peptide family, studied for urinary tract and prostate support. Research suggests it may help with bladder function and prostate microcirculation. Part of the tissue-specific bioregulatory compounds developed over 40+ years of research.
Glutathione
Clinical TrialsThe body's master antioxidant - a tripeptide composed of glutamate, cysteine, and glycine. Found in every cell at concentrations similar to glucose (5mM). Essential for detoxification, immune function, and cellular protection against oxidative stress.
DSIP
Clinical TrialsA neuropeptide that promotes deep delta wave sleep. First isolated from rabbit brains in 1977. Used for sleep optimization and stress reduction.
Educational Information Only
This information about Humanin for cardiac health is for educational purposes only. Always consult with qualified healthcare providers before using any peptide. Individual results may vary.